Founding Team

About

- MD/PhD from Washington UniversityThe founding team of EvolveImmune Therapeutics has a long and impressive history in the field of oncology and cancer research. The team includes a Senior Vice President who was previously Global Head of Oncology & Hematology Drug Development at Genentech and Roche, a Board member of CytomX Therapeutics, and a Director at Yale Cancer Center. The team also includes a Physician-in-Chief at Smilow Cancer Hospital, a Visiting Scientist at MIT, and an Assistant Professor at Yale University. Finally, the team includes a Visiting Postdoc from the Broad Institute and a Damon Runyon Cancer Research Fellow from MIT.